Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

The treatment of prolonged coma with neurostimulation.

Hosobuchi Y, Yingling C.

Adv Neurol. 1993;63:247-51. No abstract available.

PMID:
8279309
2.

Motor cortical stimulation for control of central deafferentation pain.

Hosobuchi Y.

Adv Neurol. 1993;63:215-7. No abstract available.

PMID:
8279306
3.

Descending trigeminal tractotomy for trigeminal neuralgia after surgical failure.

Morita M, Hosobuchi Y.

Stereotact Funct Neurosurg. 1992;59(1-4):52-5.

PMID:
1295047
4.

Control of the transition from sensory detection to sensory awareness in man by the duration of a thalamic stimulus. The cerebral 'time-on' factor.

Libet B, Pearl DK, Morledge DE, Gleason CA, Hosobuchi Y, Barbaro NM.

Brain. 1991 Aug;114 ( Pt 4):1731-57.

PMID:
1884176
5.

Treatment of cerebral ischemia with electrical stimulation of the cervical spinal cord.

Hosobuchi Y.

Pacing Clin Electrophysiol. 1991 Jan;14(1):122-6.

PMID:
1705326
6.

P300 as a predictor of recovery from coma.

Yingling CD, Hosobuchi Y, Harrington M.

Lancet. 1990 Oct 6;336(8719):873. No abstract available.

PMID:
1976890
7.

Cerebrospinal fluid concentrations of laudanosine after administration of atracurium.

Fahey MR, Canfell PC, Taboada T, Hosobuchi Y, Miller RD.

Br J Anaesth. 1990 Jan;64(1):105-6.

8.

The effects of cervical spinal cord stimulation (cSCS) on experimental stroke.

Matsui T, Hosobuchi Y.

Pacing Clin Electrophysiol. 1989 Apr;12(4 Pt 2):726-32.

PMID:
2470058
9.

Beneficial effects of cervical spinal cord stimulation (cSCS) on patients with impaired consciousness: a preliminary report.

Matsui T, Asano T, Takakura K, Yamada R, Hosobuchi Y.

Pacing Clin Electrophysiol. 1989 Apr;12(4 Pt 2):718-25.

PMID:
2470057
10.

Current issues regarding subcortical electrical stimulation for pain control in humans.

Hosobuchi Y.

Prog Brain Res. 1988;77:189-92. Review. No abstract available.

PMID:
2464180
11.

Headache may arise from perturbation of brain.

Raskin NH, Hosobuchi Y, Lamb S.

Headache. 1987 Sep;27(8):416-20. No abstract available.

PMID:
3667258
12.

Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources.

Gutin PH, Leibel SA, Hosobuchi Y, Crumley RL, Edwards MS, Wilson CB, Lamb S, Weaver KA.

Neurosurgery. 1987 Jun;20(6):938-45.

PMID:
3614575
13.
14.

Stereotactic heavy-particle irradiation of intracranial arteriovenous malformations.

Hosobuchi Y, Fabricant J, Lyman J.

Appl Neurophysiol. 1987;50(1-6):248-52.

PMID:
3329856
15.

Is the brain pain-insensitive?

Raskin NH, Hosobuchi Y, Lamb S.

Cephalalgia. 1987;7 Suppl 6:23-5. No abstract available.

PMID:
2964900
16.

Dorsal periaqueductal gray-matter stimulation in humans.

Hosobuchi Y.

Pacing Clin Electrophysiol. 1987 Jan;10(1 Pt 2):213-6.

PMID:
2436181
17.

Dynorphin effects on plasma concentrations of anterior pituitary hormones in the nonhuman primate.

Gilbeau PM, Hosobuchi Y, Lee NM.

J Pharmacol Exp Ther. 1986 Sep;238(3):974-7.

PMID:
2875176
18.

Effects of dynorphin1-13 on opiate binding and dopamine and GABA uptake in stroked cat brain.

Kuroda H, Baskin DS, Matsui T, Loh HH, Hosobuchi Y, Lee NM.

Brain Res. 1986 Jul 30;379(1):68-74.

PMID:
2874866
19.

Autopsy analysis of the safety, efficacy and cartography of electrical stimulation of the central gray in humans.

Baskin DS, Mehler WR, Hosobuchi Y, Richardson DE, Adams JE, Flitter MA.

Brain Res. 1986 Apr 23;371(2):231-6.

PMID:
3486027
20.
21.
22.

Use of antidromic evoked potentials in placement of dorsal cord disc electrodes.

Yingling CD, Hosobuchi Y.

Appl Neurophysiol. 1986;49(1-2):36-41.

PMID:
3490219
23.
25.

Reduced anesthetic requirement after electrical stimulation of periaqueductal gray matter.

Roizen MF, Newfield P, Eger EI 2nd, Hosobuchi Y, Adams JE, Lamb S.

Anesthesiology. 1985 Feb;62(2):120-3.

PMID:
3970361
26.

Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin 1-13.

Baskin DS, Kuroda H, Hosobuchi Y, Lee NM.

Neuropeptides. 1985 Feb;5(4-6):307-10.

PMID:
2860592
27.
28.

Dynorphin(1-13) improves survival in cats with focal cerebral ischaemia.

Baskin DS, Hosobuchi Y, Loh HH, Lee NM.

Nature. 1984 Dec 6-12;312(5994):551-2.

PMID:
6150441
29.

Pain relief from dorsal root entry zone lesions made with argon and carbon dioxide microsurgical lasers.

Powers SK, Adams JE, Edwards MS, Boggan JE, Hosobuchi Y.

J Neurosurg. 1984 Nov;61(5):841-7.

PMID:
6436446
30.
31.

Naloxone and focal cerebral ischemia.

Baskin DS, Hosobuchi Y.

J Neurosurg. 1984 Jun;60(6):1328-31. No abstract available.

PMID:
6726382
32.
33.

Use of the argon surgical laser in neurosurgery.

Powers SK, Edwards MS, Boggan JE, Pitts LH, Gutin PH, Hosobuchi Y, Adams JE, Wilson CB.

J Neurosurg. 1984 Mar;60(3):523-30.

PMID:
6538225
34.

A subcortical correlate of P300 in man.

Yingling CD, Hosobuchi Y.

Electroencephalogr Clin Neurophysiol. 1984 Feb;59(1):72-6.

PMID:
6198167
35.
36.

Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources.

Gutin PH, Phillips TL, Wara WM, Leibel SA, Hosobuchi Y, Levin VA, Weaver KA, Lamb S.

J Neurosurg. 1984 Jan;60(1):61-8.

PMID:
6358430
37.

Anesthesia does not increase opioid peptides in cerebrospinal fluid of humans.

Way WL, Hosobuchi Y, Johnson BH, Eger EI 2nd, Bloom FE.

Anesthesiology. 1984 Jan;60(1):43-5.

PMID:
6318607
38.

Proton nuclear magnetic resonance imaging of acute experimental cerebral ischemia.

Mano I, Levy RM, Crooks LE, Hosobuchi Y.

Invest Radiol. 1983 Jul-Aug;18(4):345-51.

PMID:
6618824
39.

NMR imaging of acute experimental cerebral ischemia: time course and pharmacologic manipulations.

Levy RM, Mano I, Brito A, Hosobuchi Y.

AJNR Am J Neuroradiol. 1983 May-Jun;4(3):238-41.

PMID:
6410711
41.
42.

Effect of naloxone on neurologic deficit and cortical blood flow during focal cerebral ischemia in cats.

Levy R, Feustel P, Severinghaus J, Hosobuchi Y.

Life Sci. 1982 Nov 15-22;31(20-21):2205-8.

PMID:
7162337
43.

Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effects.

Baskin DS, Kieck CF, Hosobuchi Y.

Life Sci. 1982 Nov 15-22;31(20-21):2201-4. No abstract available.

PMID:
6819421
44.

Naloxone and ischemic neurologic deficits in the gerbil: is there an effect?

Hosobuchi Y, Baskin DS.

Science. 1982 Nov 5;218(4572):594. No abstract available.

PMID:
17842064
45.

Computed tomography-directed stereotaxy for biopsy and interstitial irradiation of brain tumors: technical note.

MacKay AR, Gutin PH, Hosobuchi Y, Norman D.

Neurosurgery. 1982 Jul;11(1 Pt 1):38-42. No abstract available.

PMID:
7050762
46.

Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans.

Hosobuchi Y, Baskin DS, Woo SK.

J Cereb Blood Flow Metab. 1982;2 Suppl 1:S98-100.

PMID:
7085809
47.

Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone.

Hosobuchi Y, Baskin DS, Woo SK.

Science. 1982 Jan 1;215(4528):69-71. No abstract available.

PMID:
6274019
48.

Elevated cerebrospinal fluid substance P in arachnoiditis is reduced by systemic administration of morphine.

Hosobuchi Y, Emson PC, Iversen LL.

Adv Biochem Psychopharmacol. 1982;33:497-500. No abstract available.

PMID:
6181663
49.

Permanent and removable implants for the brachytherapy of brain tumors.

Gutin PH, Phillips TL, Hosobuchi Y, Wara WM, MacKay AR, Weaver KA, Lamb S, Hurst S.

Int J Radiat Oncol Biol Phys. 1981 Oct;7(10):1371-81. No abstract available.

PMID:
7319861
50.

Naloxone reversal of ischaemic neurological deficits in man.

Baskin DS, Hosobuchi Y.

Lancet. 1981 Aug 8;2(8241):272-5. No abstract available.

PMID:
6114322

Supplemental Content

Loading ...
Support Center